Israel’s TA-25 Index increased the most since Sept. 25, gaining 1.7 percent to 1,038.50 at the 4:30 p.m. close in Tel Aviv. Investors traded about 1.5 billion shekels ($401 million) of shares and convertible securities today, according to Tel Aviv Stock Exchange data.
The following stocks rose or fell today. Symbols are in parentheses.
Alvarion Ltd. (ALVR) snapped a three-day drop, advancing 2.9 percent to 3.92 shekels. The provider of wireless access solutions said it won a $2 million contract with Angola Communications Systems to install a high-speed wireless broadband network in the African nation.
Azrieli Group (AZRG) Ltd rose the most since Sept 15, climbing 3.1 percent to 87.84 shekels. The real estate company is in talks to sell its Granite Hacarmel Investments Ltd. (GRNT) and Sonol Israel Ltd. units, Calcalist reported. Granite, a marketer of petroleum and automobile products, increased 3.9 percent to 5.451 shekels.
BioCancell Therapeutics Inc. (BICL IT) rose to the highest level since Sept. 5, increasing 4.9 percent to 1.531 shekels. The biotechnology company began a Phase IIB trial for its pancreatic-cancer treatment that was fast-tracked by the U.S. Food and Drug Administration.
Delek Real Estate Ltd. (DLKR) rose for the first time in more than a week, soaring 11.6 percent, the most since Sept. 26, to 0.163 shekels. The property company said it completed the sale of Trois Riviers and Jean Coutu.
D.N.A. Biomedical Solutions Ltd. (DNA IT) rose 9.3 percent, the biggest gain since Sept. 25, to 0.188 shekel after it got approval to market its MiniOmni device in Canada.
Koor Industries Ltd. (KOR) rose to the highest level since Aug. 15, gaining 8.4 percent to 37.85 shekels. Discount Investment Corp. (DISI) raised its offer to acquire 3.3 million shares of the holding company to 38.5 shekels a share from 35 shekels. Discount shares rose 3.2 percent to 31.98 shekels.
RadVision Ltd. (RVSN) fell to the lowest since February 2009, tumbling 9.6 percent to 18.71 shekels. The maker of video- conferencing systems lowered its third quarter forecast.
WideMed (WDMD) Ltd advanced the most in more than a month, gaining 12.8 percent to 0.504 shekel. The company said it received approval from Canada to market its Morpheus cardio- sleep analysis product.
To contact the reporter on this story: Shoshanna Solomon in Tel Aviv at email@example.com
To contact the editor responsible for this story: Claudia Maedler at firstname.lastname@example.org